[(7S,9E,11S,13S,14R,15S,16S,17R,18S,19E,21E)-1'-benzyl-2,15,17,33-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxospiro[8,34-dioxa-24,27,30-triazapentacyclo[23.7.1.14,7.05,32.026,31]tetratriaconta-1(32),2,4,9,19,21,25(33),26,30-nonaene-29,3'-pyrrolidine]-13-yl] acetate

C49H60N4O11 — CID 135756239

IUPAC[(7S,9E,11S,13S,14R,15S,16S,17R,18S,19E,21E)-1'-benzyl-2,15,17,33-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxospiro[8,34-dioxa-24,27,30-triazapentacyclo[23.7.1.14,7.05,32.026,31]tetratriaconta-1(32),2,4,9,19,21,25(33),26,30-nonaene-29,3'-pyrrolidine]-13-yl] acetate
SMILESCO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(c4c3C2=O)=NC2(CCN(Cc3ccccc3)C2)CN=5)NC(=O)/C(C)=C/C=C/[C@H](C)[C@@H](O)[C@H](C)[C@H](O)[C@@H](C)[C@H](OC(C)=O)C1C
InChIInChI=1S/C49H60N4O11/c1-25-14-13-15-26(2)47(60)51-39-38-37(52-49(23-50-38)19-20-53(24-49)22-32-16-11-10-12-17-32)34-35(43(39)58)42(57)30(6)45-36(34)46(59)48(8,64-45)62-21-18-33(61-9)27(3)44(63-31(7)54)29(5)41(56)28(4)40(25)55/h10-18,21,25,27-29,33,40-41,44,55-58H,19-20,22-24H2,1-9H3,(H,51,60)/b14-13+,21-18+,26-15+/t25-,27?,28-,29+,33-,40+,41-,44+,48-,49?/m0/s1
InChIKeyKLQRLBIQYYRXBW-BNSXNBMWSA-N
MW881.04 g/mol
LogP4.95
Rot. Bonds4

About [(7S,9E,11S,13S,14R,15S,16S,17R,18S,19E,21E)-1'-benzyl-2,15,17,33-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxospiro[8,34-dioxa-24,27,30-triazapentacyclo[23.7.1.14,7.05,32.026,31]tetratriaconta-1(32),2,4,9,19,21,25(33),26,30-nonaene-29,3'-pyrrolidine]-13-yl] acetate

[(7S,9E,11S,13S,14R,15S,16S,17R,18S,19E,21E)-1'-benzyl-2,15,17,33-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxospiro[8,34-dioxa-24,27,30-triazapentacyclo[23.7.1.14,7.05,32.026,31]tetratriaconta-1(32),2,4,9,19,21,25(33),26,30-nonaene-29,3'-pyrrolidine]-13-yl] acetate (PubChem CID 135756239) has the molecular formula C49H60N4O11 and a molecular weight of 881.04 g/mol. Its IUPAC name is [(7S,9E,11S,13S,14R,15S,16S,17R,18S,19E,21E)-1'-benzyl-2,15,17,33-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxospiro[8,34-dioxa-24,27,30-triazapentacyclo[23.7.1.14,7.05,32.026,31]tetratriaconta-1(32),2,4,9,19,21,25(33),26,30-nonaene-29,3'-pyrrolidine]-13-yl] acetate.

Molecular Properties

Compound Name[(7S,9E,11S,13S,14R,15S,16S,17R,18S,19E,21E)-1'-benzyl-2,15,17,33-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxospiro[8,34-dioxa-24,27,30-triazapentacyclo[23.7.1.14,7.05,32.026,31]tetratriaconta-1(32),2,4,9,19,21,25(33),26,30-nonaene-29,3'-pyrrolidine]-13-yl] acetate
PubChem CID135756239
Molecular FormulaC49H60N4O11
Molecular Weight881.04 g/mol
Exact Mass880.43
IUPAC Name[(7S,9E,11S,13S,14R,15S,16S,17R,18S,19E,21E)-1'-benzyl-2,15,17,33-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxospiro[8,34-dioxa-24,27,30-triazapentacyclo[23.7.1.14,7.05,32.026,31]tetratriaconta-1(32),2,4,9,19,21,25(33),26,30-nonaene-29,3'-pyrrolidine]-13-yl] acetate
SMILESCO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(c4c3C2=O)=NC2(CCN(Cc3ccccc3)C2)CN=5)NC(=O)/C(C)=C/C=C/[C@H](C)[C@@H](O)[C@H](C)[C@H](O)[C@@H](C)[C@H](OC(C)=O)C1C
InChIInChI=1S/C49H60N4O11/c1-25-14-13-15-26(2)47(60)51-39-38-37(52-49(23-50-38)19-20-53(24-49)22-32-16-11-10-12-17-32)34-35(43(39)58)42(57)30(6)45-36(34)46(59)48(8,64-45)62-21-18-33(61-9)27(3)44(63-31(7)54)29(5)41(56)28(4)40(25)55/h10-18,21,25,27-29,33,40-41,44,55-58H,19-20,22-24H2,1-9H3,(H,51,60)/b14-13+,21-18+,26-15+/t25-,27?,28-,29+,33-,40+,41-,44+,48-,49?/m0/s1
InChIKeyKLQRLBIQYYRXBW-BNSXNBMWSA-N
XLogP4.95
TPSA209.04 Ų
H-Bond Donors5
H-Bond Acceptors14
Rotatable Bonds4
Heavy Atoms64
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500881.04
LogP ≤ 54.95
H-Bond Donors ≤ 55
H-Bond Acceptors ≤ 1014

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'catechol', 'substructure': 'N/A'}

Analyze [(7S,9E,11S,13S,14R,15S,16S,17R,18S,19E,21E)-1'-benzyl-2,15,17,33-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxospiro[8,34-dioxa-24,27,30-triazapentacyclo[23.7.1.14,7.05,32.026,31]tetratriaconta-1(32),2,4,9,19,21,25(33),26,30-nonaene-29,3'-pyrrolidine]-13-yl] acetate with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of [(7S,9E,11S,13S,14R,15S,16S,17R,18S,19E,21E)-1'-benzyl-2,15,17,33-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxospiro[8,34-dioxa-24,27,30-triazapentacyclo[23.7.1.14,7.05,32.026,31]tetratriaconta-1(32),2,4,9,19,21,25(33),26,30-nonaene-29,3'-pyrrolidine]-13-yl] acetate?
The IUPAC name of [(7S,9E,11S,13S,14R,15S,16S,17R,18S,19E,21E)-1'-benzyl-2,15,17,33-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxospiro[8,34-dioxa-24,27,30-triazapentacyclo[23.7.1.14,7.05,32.026,31]tetratriaconta-1(32),2,4,9,19,21,25(33),26,30-nonaene-29,3'-pyrrolidine]-13-yl] acetate (CID 135756239) is [(7S,9E,11S,13S,14R,15S,16S,17R,18S,19E,21E)-1'-benzyl-2,15,17,33-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxospiro[8,34-dioxa-24,27,30-triazapentacyclo[23.7.1.14,7.05,32.026,31]tetratriaconta-1(32),2,4,9,19,21,25(33),26,30-nonaene-29,3'-pyrrolidine]-13-yl] acetate.
What is the SMILES notation for [(7S,9E,11S,13S,14R,15S,16S,17R,18S,19E,21E)-1'-benzyl-2,15,17,33-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxospiro[8,34-dioxa-24,27,30-triazapentacyclo[23.7.1.14,7.05,32.026,31]tetratriaconta-1(32),2,4,9,19,21,25(33),26,30-nonaene-29,3'-pyrrolidine]-13-yl] acetate?
The canonical SMILES for [(7S,9E,11S,13S,14R,15S,16S,17R,18S,19E,21E)-1'-benzyl-2,15,17,33-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxospiro[8,34-dioxa-24,27,30-triazapentacyclo[23.7.1.14,7.05,32.026,31]tetratriaconta-1(32),2,4,9,19,21,25(33),26,30-nonaene-29,3'-pyrrolidine]-13-yl] acetate is CO[C@H]1/C=C/O[C@@]2(C)Oc3c(C)c(O)c4c(O)c(c5c(c4c3C2=O)=NC2(CCN(Cc3ccccc3)C2)CN=5)NC(=O)/C(C)=C/C=C/[C@H](C)[C@@H](O)[C@H](C)[C@H](O)[C@@H](C)[C@H](OC(C)=O)C1C.
What is the InChIKey of [(7S,9E,11S,13S,14R,15S,16S,17R,18S,19E,21E)-1'-benzyl-2,15,17,33-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxospiro[8,34-dioxa-24,27,30-triazapentacyclo[23.7.1.14,7.05,32.026,31]tetratriaconta-1(32),2,4,9,19,21,25(33),26,30-nonaene-29,3'-pyrrolidine]-13-yl] acetate?
The InChIKey is KLQRLBIQYYRXBW-BNSXNBMWSA-N. The full InChI is InChI=1S/C49H60N4O11/c1-25-14-13-15-26(2)47(60)51-39-38-37(52-49(23-50-38)19-20-53(24-49)22-32-16-11-10-12-17-32)34-35(43(39)58)42(57)30(6)45-36(34)46(59)48(8,64-45)62-21-18-33(61-9)27(3)44(63-31(7)54)29(5)41(56)28(4)40(25)55/h10-18,21,25,27-29,33,40-41,44,55-58H,19-20,22-24H2,1-9H3,(H,51,60)/b14-13+,21-18+,26-15+/t25-,27?,28-,29+,33-,40+,41-,44+,48-,49?/m0/s1.
What are the key properties of [(7S,9E,11S,13S,14R,15S,16S,17R,18S,19E,21E)-1'-benzyl-2,15,17,33-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxospiro[8,34-dioxa-24,27,30-triazapentacyclo[23.7.1.14,7.05,32.026,31]tetratriaconta-1(32),2,4,9,19,21,25(33),26,30-nonaene-29,3'-pyrrolidine]-13-yl] acetate?
[(7S,9E,11S,13S,14R,15S,16S,17R,18S,19E,21E)-1'-benzyl-2,15,17,33-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxospiro[8,34-dioxa-24,27,30-triazapentacyclo[23.7.1.14,7.05,32.026,31]tetratriaconta-1(32),2,4,9,19,21,25(33),26,30-nonaene-29,3'-pyrrolidine]-13-yl] acetate has a molecular weight of 881.04 g/mol, XLogP of 4.95, 4 rotatable bonds, 5 hydrogen bond donors, and 14 hydrogen bond acceptors.
Where does this data come from?
All data for [(7S,9E,11S,13S,14R,15S,16S,17R,18S,19E,21E)-1'-benzyl-2,15,17,33-tetrahydroxy-11-methoxy-3,7,12,14,16,18,22-heptamethyl-6,23-dioxospiro[8,34-dioxa-24,27,30-triazapentacyclo[23.7.1.14,7.05,32.026,31]tetratriaconta-1(32),2,4,9,19,21,25(33),26,30-nonaene-29,3'-pyrrolidine]-13-yl] acetate is sourced from PubChem (CID 135756239), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).